|
Post by sophie on Nov 9, 2016 17:28:23 GMT -5
I think MNKD just shifted from sell to buy with this CC. I wonder if they will get any new analysts pick up coverage.
This is still a risky investment since uptake of Afrezza has been nearly nonexistent. But wow, I have a newfound confidence in leadership after this call. I have no idea how Matt worked out that deal with Sanofi and Amphastar, but he must have some deal making skills necessary to ink more partnerships in the future. Seriously makes no sense to me why Amphistar would pardon and rewrite the contract to their detriment. At the very least you'd have expected they'd want stock or some type of compensation for all the lost revenue and profit they just lost. WOW!
|
|
|
Post by mannmade on Nov 9, 2016 17:30:06 GMT -5
They got the rights to China distribution I think. But all good by me!
|
|
|
Post by sophie on Nov 9, 2016 17:33:01 GMT -5
have they mentioned this yet? I've been in and out of the call.
|
|
|
Post by radgray68 on Nov 9, 2016 17:59:08 GMT -5
Amphistar realizes they have more future in renegotiating and saving the business relationship now rather than getting in the back of the line for pennies on the dollar in bankruptcy. BTW, the threat of bankruptcy protection can work in our favor too. You're not going to hear that from many, but it is a negotiating tool Matt has at his disposal. A $130 million dollar turn-around in company value is HUGE. Great call today
|
|
|
Post by sophie on Nov 9, 2016 18:07:54 GMT -5
The part I'm most excited about is they seem to be much more organized and focused and seem to have a solid plan. It's truly confusing to me how Matt morphed from CFO to CEO the way he has. What in the world was Hakan doing for all those years? Wasn't Al the brains behind the development of TS?
In any case, this leadership team has a vision and they seem like they know how to implement it. They won't be the reason Afrezza fails. It'll truly just be that doctors/patients don't want it. I don't think that will be the case....
|
|
|
Post by esstan2001 on Nov 9, 2016 18:11:52 GMT -5
The presentation slides for Ray had 2017 for label submission and epi... Matt commented that epi was being submitted next month... so I am hopeful that both 17's were typos. Was hoping an analyst would call in to confirm, but... oh well.
Remaining question which seems obvious, is that the label update submission should be in 2016. Anyone care to comment?
|
|
|
Post by mnkdnewbie on Nov 9, 2016 18:12:55 GMT -5
Commercials commercials commercials straight from source, most exciting call I've heard in 2 years....
|
|
|
Post by mnkdnewbie on Nov 9, 2016 18:16:21 GMT -5
Truthfully I know buyers who bought at .48 today and I called them bozos now I gotta scrape some money and get more sub 1.00
|
|
|
Post by sophie on Nov 9, 2016 18:16:50 GMT -5
The presentation slides for Ray had 2017 for label submission and epi... Matt commented that epi was being submitted next month... so I am hopeful that both 17's were typos. Was hoping an analyst would call in to confirm, but... oh well. Remaining question which seems obvious, is that the label update submission should be in 2016. Anyone care to comment? I believe it was Dr. Urbanski who was talking at that time, but he said he expects a decision in Q4 2017. He said it will take about 10 months for review and decision from FDA.
|
|
|
Post by sophie on Nov 9, 2016 18:17:47 GMT -5
Truthfully I know buyers who bought at .48 today and I called them bozos now I gotta scrape some money and get more sub 1.00 The trick now is to not get greedy again... I'm not sure how I want to approach it this time. I think I'll sell off half at $2 and leave the rest in for a semi decent profit.
|
|
|
Post by mnkdnewbie on Nov 9, 2016 18:18:48 GMT -5
Yes label change has been submitted to fda and expect q4 2017.
|
|
|
Post by esstan2001 on Nov 9, 2016 18:22:20 GMT -5
The presentation slides for Ray had 2017 for label submission and epi... Matt commented that epi was being submitted next month... so I am hopeful that both 17's were typos. Was hoping an analyst would call in to confirm, but... oh well. Remaining question which seems obvious, is that the label update submission should be in 2016. Anyone care to comment? I believe it was Dr. Urbanski who was talking at that time, but he said he expects a decision in Q4 2017. He said it will take about 10 months for review and decision from FDA. Yes, I think you are right. Will have to go back to listen. Blows the theory that the label change could be a 30-90 day response. Can you say F- DelAy?
|
|
|
Post by shake34 on Nov 9, 2016 18:23:51 GMT -5
I thought I saw rls on bottom of last slide but I didn't hear matt say anything about. Are we still getting milestone payment from them this year?
|
|
|
Post by patten1962 on Nov 9, 2016 18:42:16 GMT -5
Not sure where to ask this. 97 million shares short per the NASDAQ site. How do you think this will play out tomorrow?
|
|
|
Post by traderdennis on Nov 9, 2016 18:50:56 GMT -5
Up a bit. Lots of shorts are hanging on until 2017 for tax purposes. They probably have been shorting from $5+ and were waiting for bankrupcy or a better tax treatment. Not all 97MM are going to try to cover, this is not going to cause a short squeeze.
|
|